- Home
- Equipment
- asia middle east
- cancer cell
Show results for
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- Hong Kong
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Cancer Cell Equipment Supplied In Asia Middle East
72 equipment items found
Manufactured by:Mol Scientific based in, CHINA
Mol Scientific offer high-quality Cancer cell proliferation inhibitor peptide product(MPE0003430). Mol Scientific committed to bring our esteemed customers high quality products and the finest services at highly competitive prices. ...
Manufactured by:Santa Cruz Biotechnology, Inc. based inDallas, TEXAS (USA)
Pladienolide B is a highly potent splicing inhibitor of both hypoxia signals and cancer cell ...
by:Alfa Cytology based inU.S. VIRGIN ISLANDS
CM03 stabilizes G4, downregulates more G4-containing genes, and increases the incidence of double-strand break events (DSBs) due to torsional strains on DNA and chromatin structures. CM03 has selective potency against pancreatic cancer cells. ...
by:Alfa Cytology based inU.S. VIRGIN ISLANDS
ICy-OH can not only be used for deep tissue imaging (λex=640 nm, λem=690-740 nm), but also selectively induce pancreatic cancer cell death through the pyroptosis pathway. ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
This drug combines the advantages of two factors: target specificity, which is a characteristic of an antibody, and cytotoxicity, which is a characteristic of a drug. Specifically, this is a technology focused on targeting and killing cancer cells by delivering drugs that cause cytotoxicity to tumor cells using antibodies that can bind to ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
PLX-Immune are cells that have been induced with tumor necrosis factor alpha (TNF-a) and interferon-gamma (IFN-g), to transiently alter their secretion profile. The product has been evaluated in pre-clinical studies and a peer-reviewed article in the journal Scientific Reports, from Nature, was published which examined the effect of the cells in over 50 lines of ...
by:Pars Isotope Co based inTehran, IRAN
The PARS-LUTOPSMA kit is an innovative theranostic radiopharmaceutical developed by Parsisotope Company, designed specifically for the treatment of metastatic prostate cancer. This kit is notable for being the first of its kind globally, and is used in conjunction with the Lu-177 radioisotope. It targets prostate-specific membrane antigen (PSMA), a membrane glycoprotein, the ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
Chemotherapy drugs have many side effects such as reduction in white blood cells, hair loss, vomiting because they attack rapidly growing cells without separating cancer cells from normal cells. However targeted therapy drugs have less side effects because they detect and attack specific targets that exist only ...
by:Alfa Cytology based inU.S. VIRGIN ISLANDS
P12FR2 aptamer sodium is a 2'-fluoropyrimidine-modified RNA aptamer targeting human PAUF with an estimated apparent KD of 77 nM. The P12FR2 aptamer sodium inhibits PAUF-induced migration of PANC-1 (human pancreatic cancer cells) in a wound healing assay and suppresses tumor growth in a mouse CFPAC-1 pancreatic cancer ...
Manufactured by:TxinnoBioscience Inc. based inYongin-si, SOUTH KOREA
Txinno Bioscience is developing anti-cancer treatments focused on two intertwined aspects of physiology of tumor tissue. The first one is defined as tumor-intrinsic factors which are either genes or signaling pathways of tumor cells to directly control tumor cell proliferation or survival. Corresponding assets are ULK1 inhibitor, target S ...
Manufactured by:Panagene Inc. based inDaejeon, SOUTH KOREA
Lung cancer is a metastatic cancer which the cancer cells are developed in the bronchial tubes or alveoli and grow along the blood vessel or lymphatic vessel. There are two types of lung cancer based on the sizes and shape of the cancer cell; non-small cell lung ...
Manufactured by:TxinnoBioscience Inc. based inYongin-si, SOUTH KOREA
By hydrolyzing cGAMP (natural ligand of STING) into AMP and GMP, ENPP1 negatively regulates STING-mediated type I interferon production and subsequently prevents innate immune response against tumor. It was suggested that cancer cells acquire immune evasiveness by increasing ENPP1 expression, reflecting over-expression of ENPP1 in many different ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
CTCs(Circulating Tumor Cells) are cancer cells found in blood during metastasis. Being very rare, with one CTC per one billion hematopoietic cells, highly specific and sensitive technologies are imperative for their isolation. Geno CTC ver.3 allow high throughput and more accurate separation of CTCs from whole blood. ...
Manufactured by:Lineage Cell Therapeutics, Inc. based inCarlsbad, CALIFORNIA (USA)
VAC2 is an allogeneic, or non-patient specific, cancer vaccine candidate designed to stimulate patient immune responses to telomerase which is commonly expressed in cancerous cells but not in normal adult cells. VAC2, which is produced from our pluripotent cell technology using a directed differentiation ...
Manufactured by:CatchGene Co., Ltd based inNew Taipei City, TAIWAN
Everyone has Circulating cell-free DNA in our circulating system. In times past, people thought Circulating cell-free DNA were “junk” or just for recycling. But in the past two decades, scientists realized that not only normal cells but also cancer cells, embryo or even transplant organs will release ...
Manufactured by:Sysmex Corporation based inChuo-ku, JAPAN
Also, it takes more than one hour for the gene amplification reaction. Sysmex has developed the one-step measurement technology for cancer cell derived biomarkers (CK19mRNA) in the lymph node by optimizing composition of the pretreatment (homogenization) liquid and the raw materials (enzymes and primers) to enable elimination of process of the nucleic acid ...
Manufactured by:Elpiscience based inShanghai, CHINA
ES004 is a potentially best-in-class antibody targeting pan-allele signal-regulatory protein alpha (SIRPα). SIRPα is an inhibitory receptor expressed only on myeloid cells and dendritic cells. Binding of CD47 to SIRPα delivers a “don’t eat me” signal to suppress phagocytosis. Tumor cells frequently overexpress CD47 to evade macrophage-mediated destruction. To ...
Manufactured by:Takeda Pharmaceutical Company Limited based inChuo-ku, JAPAN
Bortezomib (brand name: Velcade) is a treatment for multiple myeloma (a cancer of the plasma cells) and mantle cell lymphoma (a cancer of the lymph ...
Manufactured by:Elpiscience based inShanghai, CHINA
The SIRPα antibody blocks the “don’t-eat-me” signal while the TAA antibody provides an “eat-me” signal through Fc receptor engagement. ES028 and the BiME platform are designed for potent activation of phagocytosis and directly kill tumor cells for treatment of solid tumors. We expect to develop ES028 as a monotherapy to provide an ...
Manufactured by:Beijing Challen Biotechnology Co., Ltd. based inDaxing District, CHINA
50 tests/box; 100 tests/box. Detection method: flow antibody method. Scope of application: Detect the expression of CD3 in human biological specimens and provide doctors with auxiliary information for diagnosis. Testable items: detection of lymphocyte subpopulations, regulatory T cells, PD-1, expressed in blast cells of acute T-ceii leukemia and tumor cells of mature T-ceii ...